Progyny, Inc.

PGNY Healthcare Healthcare Plans

Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.

Revenue
+8.91%
EPS
+115.3%
Free cash flow
+2.72%

Quarter to September 2026, against a year earlier

34.84 0.47 +1.37%
Market cap
$2.6B
P/E
30.1×
Fwd P/E
26.4×
Dividend yield
—
F-score
8/9
Altman Z
8.89
Beneish M
−3.45
Dividend safety
n/a

Progyny, Inc. (PGNY) P/S ratio

Alert me on P/S ratio

As of 6 November 2026, Progyny, Inc. (PGNY) trades at a P/S ratio of 2.0×. Over the past ten years it has ranged from 0.6× (October 2019) to 14.7× (June 2021); the current reading is higher than 35% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.7× 34.60%
FY2024 1.3× (60.96%)
FY2023 3.2× (9.37%)
FY2022 3.6× (60.01%)
FY2021 9.0× (14.95%)
FY2020 10.5× 325.21%
FY2019 2.5× 300.21%
FY2018 0.6× 0.00%
FY2017 0.6× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.4× (16.57%)
Jun 2026 1.7× 61.79%
Mar 2026 1.1× (37.74%)
Dec 2025 1.7× 16.98%
28 more quarters

Against its own ten years

Low 0.6× High 14.7×
Ten-year median 3.4×
Current reading's percentile 35

P/S ratio against peers

Company P/S ratio
CNC Centene Corporation compare 0.2×
MOH Molina Healthcare, Inc compare 0.2×
CI Cigna Group compare 0.3×
ALHC Alignment Healthcare, Inc. compare 0.3×
HUM Humana Inc. compare 0.3×
ELV Elevance Health, Inc. compare 0.5×
OSCR Oscar Health, Inc. compare 0.5×
CLOV Clover Health Investments, Corp. compare 0.9×
PGNY Progyny, Inc. 2.0×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on PGNY